News Related to Gastric Cancers

Related coverage linked through entity extraction aliases.

AstraZeneca, Daiichi Sankyo Seek Regulatory Approvals for Enhertu in Early Breast Cancer

Mar 10, 2026

The US FDA granted priority review and the European Medicines Agency validated applications for Enhertu as post-neoadjuvant treatment for HER2-positive early breast cancer, based on Phase III trial data showing 53% reduction in recurrence risk.

PD-1 and PD-L1 Inhibitors Market Expands with 200+ Drugs in Development Across 180+ Companies

Feb 19, 2026

A comprehensive market report reveals over 180 companies are developing more than 200 PD-1 and PD-L1 inhibitor drugs, with recent fast-track designations and successful Phase III trial results driving expansion in cancer immunotherapy.